Correction to “Commercial Synthesis of a Pyrrolotriazine-Fluoroindole

Addition/Correction pubs.acs.org/OPRD

Correction to “Commercial Synthesis of a PyrrolotriazineFluoroindole Intermediate to Brivanib Alaninate: Process Development Directed toward Impurity Control” Jaan A. Pesti,* Thomas LaPorte, John E. Thornton, Lori Spangler, Frederic Buono, Gerard Crispino, Frank Gibson, Mourad Hamedi, Paul Lobben, and Christos G. Papaioannou Bristol-Myers Squibb Company, Early Phase Chemical Development, New Brunswick, New Jersey 08923, United States

Org. Process Res. Dev. 2014, 18 (1), 89−102. DOI: 10.1021/op400242j In the original manuscript, the author Mourad Hamedi was missing. The correct author list is shown above.

Published: August 31, 2015 © 2015 American Chemical Society

1323

DOI: 10.1021/acs.oprd.5b00262 Org. Process Res. Dev. 2015, 19, 1323−1323